Both in Pharmaceuticals
Aptevo Therapeutics vs Ernexa Therapeutics
Over the past year APVO returned −94.8% and ERNA returned −95.2%; their daily moves had a correlation of -0.06.
APVO −94.8% ERNA −95.2%Growth of $1, one year, split-adjusted
| Metric | APVO | ERNA |
|---|---|---|
| Price | $1.38 | $2.00 |
| Market cap | $2.5M | $2.3M |
| Today | +2.99% | +1.52% |
| 1 month | −21.6% | −32.4% |
| 6 months | −74.7% | −46.5% |
| Year to date | −85.4% | −93.3% |
| 1 year | −94.5% | −95.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 112.9% | 79.8% |
| Short % of float | 5.8% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).